Insider Shareholders with Direct Ownership of Roivant Sciences Ltd. (ROIV)
This section provides a comprehensive overview of the insiders with direct ownership of Roivant Sciences Ltd. (ROIV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Roivant Sciences Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dexcel Pharma Technologies Ltd.
> 10% Shareholder |
4,040,285 | 0 | 102,849,443 $1.2 Billion | 3 |
Nov 10, 2022
Added 3.74%
|
|
Vivek Ramaswamy
> 10% Shareholder |
1,029,735 | 7,509,520 | 51,929,426 $607 Million | 12 |
Jan 02, 2024
Reduced 5.46%
|
|
Mayukh Sukhatme
Pres&Chief Investment Officer |
19,830,018 | 366,211 | 22,488,532 $263 Million | 8 |
Jul 26, 2024
Added 43.05%
|
|
Matthew Gline
CEO |
19,290,133 | 3,610,687 | 17,361,059 $203 Million | 50 |
Oct 20, 2024
Reduced 0.06%
|
| 86,373 | 3,309,862 | 7,289,093 $85.1 Million | 7 |
Sep 12, 2024
Reduced 0.04%
|
|
| 86,373 | 503,000 | 1,277,178 $14.9 Million | 5 |
Sep 25, 2024
Reduced 9.56%
|
|
|
Eric Venker
President & COO |
4,300,950 | 5,072,473 | 617,470 $7.21 Million | 103 |
Oct 21, 2024
Reduced 13.94%
|
|
Richard Pulik
CFO |
105,395 | 57,410 | 278,942 $3.26 Million | 26 |
Oct 28, 2024
Reduced 0.83%
|
|
Rakhi Kumar
Chief Accounting Officer |
775,035 | 831,900 | 208,366 $2.43 Million | 67 |
Oct 20, 2024
Reduced 0.46%
|
| 110,315 | 12,459 | 97,856 $1.14 Million | 17 |
Oct 21, 2024
Added 2.3%
|
|
| 104,460 | 10,788 | 93,665 $1.09 Million | 17 |
Oct 21, 2024
Added 1.3%
|
|
| 52,142 | 0 | 52,142 $609,018 | 1 |
Sep 15, 2022
Added 50.0%
|
|
| 42,405 | 4,368 | 38,037 $444,272 | 10 |
Oct 21, 2024
Added 4.07%
|
|
| 30,353 | 977 | 29,376 $343,111 | 8 |
Sep 12, 2024
Reduced 2.95%
|